Dexmedetomidine Versus Propofol for Prolonged Sedation in Critically Ill Trauma and Surgical Patients



Status:Completed
Conditions:Hospital, Neurology
Therapuetic Areas:Neurology, Other
Healthy:No
Age Range:18 - Any
Updated:4/21/2016
Start Date:November 2014
End Date:April 2015

Use our guide to learn which trials are right for you!

The purpose of this study is to assess the efficacy of dexmedetomidine versus propofol for
prolonged sedation in trauma and surgical patients.

Design: Open-label, single-center prospective study. Setting: Trauma/Surgical Intensive Care
Unit (TSICU) at a Level I academic trauma center.

Patients: Patients 18 years of age or older requiring mechanical ventilation and admitted to
the TSICU Interventions: Patients were randomly assigned based on unit bed location to
receive dexmedetomidine or propofol for sedation.

Inclusion Criteria:

- Patients were included in the study if they were 18 years of age or older,

- mechanically ventilated,

- placed on the institutional sedation protocol,

- expected to require sedation lasting 24 hours after randomization, and

- admitted to the TSICU and followed by the Trauma/Surgical Service.

Exclusion Criteria:

Patients were excluded for any of the following:

- 72 hours or greater since sedation protocol initiation,

- treatment per the institutional traumatic brain injury (TBI) protocol,

- concomitant continuous infusion of a neuromuscular blocking agent,

- heart rate less than 50 beats per minute,

- mean arterial pressure less than 55 mmHg despite fluid resuscitation and
vasopressors, and

- use of other alpha-2 agonists within 24 hours of randomization.
We found this trial at
1
site
Knoxville, Tennessee 37920
?
mi
from
Knoxville, TN
Click here to add this to my saved trials